Skip to content

actiTENS Android app

by Sublimed

actiTENS Android app (SBM2AA110) is a medical device (FDA Class II) made by Sublimed, cleared under FDA 510(k) K252767 on 16 Jan 2026 (1 earlier submission), registered in EUDAMED and listed in FDA GUDID since 24 Apr 2024 (UDI-DI B786SBM2AA1100), active as of 2 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE MDR CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 2 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 2 Nov 2026.

Regulatory status

as of registry sync 2 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k) GUDID from GUDID NumberK252767 Date16 Jan 2026IssuedStatusActive
United StatesGUDID listing GUDID NumberB786SBM2AA1100 UDI-DI Date24 Apr 2024ListedStatusListed GUDID: in commercial distribution
European UnionCE/MDR EUDAMED Number— Date—StatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Device description
actiTENS is a transcutaneous electrical nerve stimulation (TENS) medical device designed to manage chronic pain in people. The compact design and flexible shape of the actiTENS electrical impulse generator allows to fix it for daily use directly to the body of the patient. The impulse generator is delivered with a separate cradle which allows safely recharging its non- removable battery. The actiTENS is compatible with a selection of disposable electrodes and compatible connector cables transmit the electrical stimulation impulses to the targeted nerves according to the selected therapy. The electrical stimulation waveforms are biphasic and asymmetric. The actiTENS is controlled via a downloadable mobile app which allows the comfortable and simple selection of the adequate stimulation program. The actiTENS is intended to be used by the patient at home and also for therapeutic application by medical professionals. It is available for prescription only.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 2 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • FDA 510(k) K252767 decided 16 Jan 2026 Active· +1 more in the status table
  • EUDAMED Active· +1 more in the status table
  • FDA GUDID UDI-DI B786SBM2AA1100 listed 24 Apr 2024 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K202159
  2. Listed FDA GUDID B786SBM2AA1100
  3. Cleared FDA 510(k) K252767

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR, CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
actiTENS
Generic name
Analgesic transcutaneous electrical nerve stimulation system
Model / Ref / Catalog
actiTENS Android app, SBM2AA110
Primary DI / UDI-DI
B786SBM2AA1100
510(k) Number
FDA product code
GZJ, IPF, NGX, NYN, NUH
GMDN term
Analgesic transcutaneous electrical nerve stimulation system
Device class
Class II
Regulation number
882.5890, 890.5850
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Analgesic transcutaneous electrical nerve stimulation system.

Other devices from Sublimed

See all devices from Sublimed →

Properties

  • Prescription use
  • Over-the-counter
  • Lot / batch number
Other properties (12, all answered No)